drugset
Drugs / Panhematin
last change Feb 2022 re-read 3 minutes ago

Panhematin

also known as hematin for injection · hemin · hemin for injection

Small molecule

Developed for
myelodysplastic syndrome · porphyria
Investigated by
H. Lundbeck A/S · Rush University Medical Center · The University of Texas Medical Branch, Galveston

Trials 2

today NCT02180412 · Ph 2 NCT00467610 · Ph 2
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02180412 Apr 2014 → Feb 2022 porphyria The University of Texas Medical Branch, Galveston Completed No outcome recorded
Phase 2 NCT00467610 May 2007 → Dec 2008 myelodysplastic syndrome Rush University Medical Center Terminated No outcome recorded

Press releases naming this drug 1 release

DateIssuerRelease
2017-07-07 RECORDATI GROUP Recordati Rare Diseases Introduces New PANHEMATIN® (Hemin for Injection) Dosage Strength for Treatment of Acute Intermittent Porphyria (AIP), recordati.com ↗

Evidence & citations 6 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Panhematin ClinicalTrials.gov intervention name — accepted as the source's own label NCT02180412 ↗
1

NCT00467610 ↗
Known as hematin for injection “The objective of this study is to evaluate the safety and efficacy of Panhematin® (hematin for injection) in the treatment of adult patients” NCT00467610 ↗
Known as hemin “This study aims to provide high quality evidence for the effectiveness and safety of hemin (PanhematinTM , Recordati) for treatment of acute attacks of porphyria.” NCT02180412 ↗
Known as hemin for injection “We are proposing a novel approach for the treatment of patients with low-risk MDS using heme supplementation with Panhematin® (hemin for injection).” NCT00467610 ↗
Action Inhibit “presumably, as a result of the inhibition of aminolevulinic acid synthetase” NCT00467610 ↗
Modality Small molecule “Panhematin® is an iron-containing metalloporphyrin” NCT00467610 ↗